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Alternative Splicing QTLs in European and African Populations
Halit Ongen1,2,3,* and Emmanouil T. Dermitzakis1,2,3,4,5,*
With the advent of RNA-sequencing technology, we can detect different types of alternative splicing and determine how DNA variation
regulates splicing. However, given the short read lengths used inmost population-based RNA-sequencing experiments, quantifying tran-
scripts accurately remains a challenge. Here we present a method, Altrans, for discovery of alternative splicing quantitative trait loci
(asQTLs). To assess the performance of Altrans, we compared it to Cufflinks andMISO in simulations and Cufflinks for asQTL discovery.
Simulations show that in the presence of unannotated transcripts, Altrans performs better in quantifications than Cufflinks and MISO.
We have applied Altrans and Cufflinks to the Geuvadis dataset, which comprises samples from European and African populations, and
discovered (FDR¼ 1%) 1,427 and 166 asQTLs with Altrans and 1,737 and 304 asQTLs with Cufflinks for Europeans and Africans, respec-
tively. We show that, by discovering a set of asQTLs in a smaller subset of European samples and replicating these in the remaining larger
subset of Europeans, both methods achieve similar replication levels (95% for both methods). We find many Altrans-specific asQTLs,
which replicate to a high degree (93%). This is mainly due to junctions absent from the annotations and hence not tested with Cufflinks.
The asQTLs are significantly enriched for biochemically active regions of the genome, functional marks, and variants in splicing regions,
highlighting their biological relevance. We present an approach for discovering asQTLs that is a more direct assessment of splicing
compared to other methods and is complementary to other transcript quantification methods.Introduction
In eukaryotes, alternative splicing is involved in develop-
ment, differentiation,1 and disease2 in a tissue-specific
manner. Splicing events can be categorized under skipped
exon, retained intron, alternative 30 or 50 splice sites, mutu-
ally exclusive exons, alternative first or last exons, or tan-
dem UTR categories. Before the invention of microarray
technology, the proportion of multi-exonic genes under-
going alternative splicing was estimated at approximately
50%.3 However, as the technology improved, these esti-
mates increased to 74% with microarrays4 and to almost
100% with RNA sequencing.5 Although RNA sequencing
has been a very powerful tool in discovering unique tran-
scription in tissues and diseases6 and also in elucidating
the regulation of transcription,7–10 accurately quantifying
transcripts remains a challenge due to the short read
length used in most population-based studies. Currently
there are multiple transcript quantification methods avail-
able including de novo quantification methods like Cuf-
flinks11 and Scripture12 and annotation-based methods
like MISO13 and Flux Capacitor.8 However, both ap-
proaches have inherent flaws because de novo methods
make the assumption that the most parsimonious solution
best describes the underlying transcriptome and annota-
tion-based methods assume complete knowledge of the
transcriptome, both of which are unlikely to be true.
In this study we present a method for relative quantifica-
tion of splicing events from RNA-sequencing data called Al-
trans. Our approach is an annotation-basedmethod, which
makes the least number of assumptions from the annota-1Department of Genetic Medicine and Development, University of Geneva M
mics in Geneva (iGE3), University of Geneva, 1211 Geneva, Switzerland; 3Sw
lence for Genomic Medicine Research, King Abdulaziz University, Jeddah 21
Athens 11527, Greece
*Correspondence: halit.ongen@unige.ch (H.O.), emmanouil.dermitzakis@unig
http://dx.doi.org/10.1016/j.ajhg.2015.09.004. 2015 The Authors
This is an open access article under the CC BY-NC-ND license (http://creative
The Americtion.To this endwechose to simplify theproblemandquan-
tify relative frequencies of observed exon pairings in RNA-
sequencing data for all categories of splicing events. This
approach assumes only correct knowledge of the exons in
the transcriptome and is agnostic to the isoform structures
defined in an annotation, which would, in theory, make it
more accurate and sensitive in thepresenceofunknown iso-
forms.We tested theperformanceofAltransversus twowell-
established transcript quantification methods, Cufflinks11
and MISO,13 and benchmarked our method in two ways.
First, we conducted a simulation study and assessed the
concordance of the measured quantifications by each
method with the simulated quantifications. Second, we as-
sessed the relative power of discovering alternative splicing
quantitative trait loci (asQTLs) for each method. For the
asQTL analyses, we chose the Geuvadis dataset, since it
was, at the time of analyses, the largest publically available
population-based RNA-sequencing study. The Geuvadis da-
taset comprises 462 individuals in the 1000 Genomes proj-
ect14 from five populations—the CEPH (CEU), Finns (FIN),
British (GBR), Toscani (TSI), and Yoruba (YRI)—and con-
tains data for whole-genome DNA sequencing and deep
mRNA sequencing in the lymphoblastoid cell line (LCL)7
and is thus an ideal dataset for our purposes.
Material and Methods
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Figure 1. Schematic of the Altrans Algo-
rithm
(A) Overlapping exons are grouped into
exon groups where identical exons
belonging to multiple transcripts are
treated as one unique entity. Two tran-
scripts, shown as connected brown and
green boxes, result in two exon groups
and three exons shown as blue boxes.
Next, the unique regions of each exon, de-
picted as light blue boxes and a subscript u
followed by the level of the exon, are iden-
tified. Because E2 has a region that is not
shared by any other exon, it is assigned a
‘‘level’’ of 1, and the reads aligning to
E2u,1 can be unambiguously assigned to
E2. E1 does not have a unique portion,
and therefore the level 1 exon, E2, is
removed from the exon group and the
whole of E1 becomes a unique portion,
shown as an empty blue box, with a level
of 2. These unique regions are used when
assigning mate pairs to links as shown
with the red lines where the solid portions
of the line are the sequencedmates and the
dashed part represents the inferred insert.
(B) The default method for calculating link
coverage. Link coverage is necessary to
normalize the observed counts for the
length of the unique portions being linked
and the insert size. The theoretical minimum and maximum insert sizes linking the two unique portions, represented as brown and
green lines, respectively, are calculated and given the empirically determined insert size distribution, and the area under the curve be-
tween the minimum and maximum insert sizes is estimated. The link coverage equals the number of mate pairs linking the two unique
portions over the ratio of this area to the area of the whole insert size distribution.
(C) The degrees of freedommethod for determining link coverage. Here given a read length and insert size of 3 and two exons that are 6
and 5 bases long, there are three mate pair alignments that can link these two exons. Therefore, the degrees of freedom refer to the theo-
retical number of positions where a mate pair (given, in this case, 3þ3þ3 ¼ 9 bp long fragment size) exists that links these exons on the
mRNA, shown as black lines. The link coverage is the number of mate pairs linking the exons over the degrees of freedom.
(D) The equation to calculate F value for a link.
(E) A worked example of calculation of the F values. First the coverage of E2 to E3 link (CE2  E3) is determined from level 1 unique
regions (CE2u,1  E3u,1), which is then subtracted from the coverage attained from the pseudo-unique E1 to E3 link (CE1u,2  E3u,1)
in order to calculate the true E1  E3 coverage (CE1  E3). In the forward direction, E1 and E2 become primary exons and in the reverse
direction E3 is the primary exon and the corresponding F values are calculated as shown.from an RNA-seq experiment and an annotation file in GTF format
containing exon locations. The BAM file is read using the
BamTools API.16 Altrans utilizes paired end reads, where one
mate maps to one exon and the other mate to a different exon,
and/or split reads spanning exon-exon junctions to count ‘‘links’’
between two exons. For reads aligning to multiple locations in the
genome with the same mapping quality, only the primary align-
ment, i.e., the one reported in the BAMfile, is considered and alter-
native alignments that are reported as tags in the BAM file are
ignored. The first exon in a link is referred to as the ‘‘primary
exon.’’ The algorithm is as follows:
1. Groupoverlappingexons fromannotation intoexongroups.
Because we are quantifying splicing events and not individ-
ual transcripts, transcript level information is ignored and
exonswith identical coordinates belonging tomultiple tran-
scripts are treated as one unique exon (Figure 1A).
2. In order to assign reads to overlapping exons, identify
unique portion(s) of each exon in an exon group. Exons
with immediate unique portions, where there is no other
overlapping exon and where a read can be unambiguously
assigned to the exon (E2u,1 in Figure 1A), are called ‘‘level 1
exons.’’ For exons with no unique positions, remove the568 The American Journal of Human Genetics 97, 567–575, October 1, 2level 1 exons from the exon group to determine regions
that identify the remaining exons uniquely, where again
there is no other overlapping exon after the removal of the
level 1 exons (E2u,2 in Figure 1A), and increment the level
of these exons. In the rare caseswhere an exon shares its start
position with one exon and its end position with another,
causing it to have no unique portion, then this exon is
removed from the analysis in order to be able to assign
unique portions to the remaining exons in the same exon
group. In cases where a larger exon overlaps and fully con-
tains two smaller exons, the insert size distribution is used
to probabilistically assign links between the two smaller
exons (please refer to the Altrans manual for a more detailed
annotation of these rare cases). Iterate through this process
of removing exons that have unique regions until all exons
in a group have unique portions (Figure 1A).
3. Use these unique portions to assign mate pairs or split reads
to links (Figure 1A). Links assigned to unique portions that
exist only after the removal of overlapping exons are puta-
tive assignments and ‘‘deconvolution’’ of these is handled
in the next step.
4. Because all the exons have ambiguous unique portions and
share regions with other exon(s), reads aligning here might015
belong to multiple exons. In order to unambiguously quan-
tify links between these exons, we calculate ‘‘link coverage’’
for all pairs of exons in a given window size. The default
method divides the link counts with the probability of
observing such a link given the insert size distribution,
which is empirically determined from pairs aligning to
long exons (Figure 1B). The second method involves calcu-
lating the number of degrees of freedom linking two exons
given the empirically determined most frequent insert size
and read length (Figure 1C). This is an alternative model
to calculating link coverage, but we recommend using the
default model unless you have a very tight distribution of
insert sizes. The link coverage metric ensures that the link
counts are normalized for the specific insert size distribution
of the experiment, which has direct effect on the observed
link counts. Hence, link coverage allows us to quantify an
exon link from the unique portions only, i.e., this value
should be equivalent to the one we would calculate if we
were able tomeasure the whole exon. The coverage between
level 1 exons can be calculated directly using the unique
portions, whereas links between higher-level exons are
calculated by iteratively subtracting coverage of all the other
lower level links from the coverage of these links (Figure 1E).
5. Calculate the quantitative metric, F value, for one exon link
as the coverage of the link over the sum of the coverages of
all the links that the primary exon makes (Figures 1D and
1E). Using this fraction rather than link counts or coverage
ensures that the metric is independent of global effects on
gene expression.
6. Repeat step 5 in both 50-to-30 (forward) and 30-to-50 (reverse)
directions to capture splice acceptor and donor effects,
respectively (Figure 1E).
Please refer to the Altrans manual where the method is anno-
tated in more detail and examples of how to run Altrans are pro-
vided. The program also allows the user to calculate an F value
from all the links that a primary exon makes regardless of the di-
rection. Along with the F values, the raw link counts are also
outputted, which allow filtering of results eliminating low count
links. These raw counts can also be normalized and subsequently
reread by the program to calculate the F values. Memory usage and
speed heavily depend on the complexity of the annotation and
the number of reads in the alignment file. For a sample alignment
with 50 million reads and an annotation with 539,748 unique
exons, Altrans ran for 20 min and consumed 784 MB of RAM on
a single 2.2 GHz core under Linux.Conversion of Transcript Quantifications to Link
Quantifications
We convert the transcript quantifications generatedwith Cufflinks
to relative link quantifications. This is achieved by assigning the
same quantification to all linked exons of a transcript based on
the measured quantification of the said transcript. We then apply
the samemethod of relative link quantification used in the Altrans
algorithm, specifically steps 5 and 6 in the previous section, to
calculate the F value for all the links a primary exon makes.Simulation Analysis
In order to benchmark the link quantifications generated by
Altrans, we conducted a simulation analysis using the Flux Simu-
lator software.17 We simulated an RNA-sequencing experimentThe Americwith 50 million reads with the GENCODE v.12 annotation18 re-
flecting cases where we have a perfect annotation describing all
the observed transcripts in the data. Additionally, we introduced
novel transcripts, made up of existing exons of a gene, into the
annotation. This was achieved by creating novel combinations
of exons of a gene while checking for compatibility of the
randomly selected exons (non-overlapping, order matches the
genomic order, and where a UTR or first or last exon is not an in-
ternal exon) and keeping the distribution of number of exons of
the random transcripts similar to that of the known transcripts.
We then simulated 5 cases with 50 million reads where the novel
transcripts accounted for 5%, 10%, 25%, 50%, and 75% of all tran-
scripts, reflecting cases where the annotation is not perfect.
Altrans, Cufflinks,11 and MISO13 were run on these 6 simulated
datasets using the standard GENCODE v.12 annotation. In each
simulation, the ‘‘correct’’ quantification of a transcript is taken
as the RNA molecule count that the Flux Capacitor used to simu-
late reads for a given transcript. We have converted these ‘‘correct’’
transcript quantifications and the measured transcript quantifica-
tions of Cufflinks and MISO to exon link quantifications, as
described in the previous section, and correlated the simulated ex-
pected link quantifications with the measured link quantifications
for the three programs in the six simulation scenarios, using links
where there were overlapping reads or links that were quantified in
both the simulation and the given program. We measured the
concordance between the simulated andmeasured quantifications
via Spearman’s correlation. The estimates of novel splicing in a
dataset are done through counting the number of uniquely map-
ping split reads. We then take junctions that are represented by at
least eight split reads and check whether this junction is present in
the annotation.cis-Alternative Splicing QTL Discovery by Each
Method in the Geuvadis Dataset
The RNA-seq reads were aligned to the human reference genome
(GRCh37) using the GEM aligner19 and alignments were filtered
for properly paired and uniquely mapping reads (mapping quality
greater than or equal to 150). Genotypes originated from 1000 Ge-
nomes phase 1 data, which is based on 1,092 individuals with 53
whole-genome sequencing data, 803 exome sequencing data, and
high-quality genotyping. The genotype data were filtered for var-
iants with MAF < 5% and HWE p < 1 3 106 for each population
separately and were corrected for population stratification using
the first three and two eigenvectors for Europeans and Africans,
respectively.7 The Altrans link counts were normalized using the
first 15 principal components calculated from these link counts.
We first looked at all pairwise links between exon groups consid-
ering the union of all exons in the exon group as one entity and
filter so that we keep only pairs of exon groups that have 15 links
in 80% of the samples. Then we count the links between exons of
the initial exon group and exons of the terminal exon group and
keep only links where the exon in the initial exon group made at
least ten links with any of the exons in the terminal exon group in
at least 30% of the samples. Cufflinks quantifications were run us-
ing the annotation with the –GTF option. In the case of Cufflinks,
the transcript quantifications were converted to link quantifica-
tions and we assessed links originating from the same genes where
there were Altrans quantifications. The cis-window for asQTL dis-
covery was 1 Mb flanking the transcription start site of each gene.
The associations were run with the FastQTL package.20 The
observed nominal p values were calculated by correlating thean Journal of Human Genetics 97, 567–575, October 1, 2015 569
Figure 2. Simulation Results
Using Flux Simulator, we ran six simulations with varying levels of
unannotated transcripts. Subsequently, we ran quantifications
with three methods with the known GENCODE v.12 annotation.
We compared the simulated versus measured link quantifications
via Spearman’s rank correlation. These comparisons are shown as
colored solid lines. In order to produce a null random distribution
for each method, we took the link quantifications for each gene,
permutated these for 100 times within the links of this gene,
and measured the correlation of these random assignments with
the simulated ones. By using this sampling method stratified by
genes, we account for the variability of number of isoforms per
gene. These correlations for random assignments are shown as
dashed lines. We observe that as the percentage of novel tran-
scripts increase, the performance of Cufflinks and MISO suffer,
whereas this is not the case for Altrans, which results in best quan-
tifications with increased levels of unannotated transcripts.genotype and link quantifications, which were Gaussian trans-
formed. Subsequently, we ran permutations for each link sepa-
rately to assign empirical p values to each link. The permutation
scheme involved permuting all links of a given gene together
1,000 times and in each permutation iteration, we record the
most significant p value from an association between any variant
in the cis- window and any link of a given gene, thereby account-
ing for the dependencies among the link quantifications of a
gene, allowing us to find significant asQTL genes. From this distri-
bution of null p values we use an approximation using the beta
distribution to estimate the extremes of the null p value distribu-
tion, and using this we calculate an adjusted p value. These
adjusted p values are then corrected for multiple testing using
the qvalue R package.21
Classification of Splicing Events
The alternative splicing events were classified into ten categories:
alternative 30 splice site, alternative 30 UTR, alternative 50 splice570 The American Journal of Human Genetics 97, 567–575, Octobersite, alternative 50 UTR, alternative first exon, alternative last
exon, mutually exclusive exon, skipped exon, tandem 30 UTR,
and tandem 50 UTR. For more information on these events, refer
to Wang et al.5 We then classify each primary exon into these
classes based on all of the observed links of the primary exon.
This means that a primary exon can be involved in multiple
splicing events. From these classifications, we then calculate the
proportion of each splicing class in the pool of significant primary
exons. This method of classification was chosen because each link
quantification is dependent on the quantification of all the other
links that a primary exon makes.Functional Enrichment of asQTLs
To compare the asQTL variants to a null distribution of similar var-
iants without splicing association, we sampled genetic variants in
the same cis-window of 1 Mb surrounding the transcription start
site (TSS) and matched them to alternative splicing variants with
respect to relative distance to TSS (within 5 kb) and minor allele
frequency (within 2%). The variant effect predictor (VEP)22 tool
from Ensembl was modified to produce custom tags that
were STOP_GAINED, SPLICE_DONOR, SPLICE_ACCEPTOR, and
FRAME_SHIFT. This modified version of VEP was applied to the
imputed genotypes using the GENCODE v.1218 annotation. To
this we added information of overlap with chromatin states23
and the Ensembl regulatory build,24 which constituted our func-
tional annotation. The enrichment for a given category was calcu-
lated as the proportion between number regulatory associations in
a given category and all regulatory variants over the same propor-
tion in the null distribution of variants. The p value for this enrich-
ment is calculated with the Fisher exact test.Results
Simulation Results
The general overview of the Altrans algorithm is provided
in Figure 1. We first aimed to compare the results between
Altrans, Cufflinks, and MISO using simulations. We
compared six scenarios, one where the given annotation
perfectly described the transcripts in the simulations and
five others with 5%, 10%, 25%, 50%, and 75% novel tran-
scripts absent from the annotation (see Material and
Methods). Subsequently we quantified the six simulation
results with both algorithms using the known annotation
in all cases. For MISO we have quantified transcript abun-
dances. This was done to assess howmethods performed in
cases of complete versus incomplete transcriptome knowl-
edge. The transcript quantifications generated by Cufflinks
and MISO were transformed into link quantifications to
make them comparable to those generated by Altrans.
The results of the simulation analysis are shown in
Figure 2. We observe that Cufflinks performs better than
Altrans when the annotation is perfect, but as the percent-
age of novel transcripts in the simulations increases,
Altrans performs better because it suffers less from the
imperfect annotation used in the quantification. In com-
parison, MISO performs less well than both methods. In
order to produce a null random distribution for each
method, we took the link quantifications for each gene1, 2015
Table 1. Number of Genes Tested and asQTLs Discovered at FDR ¼ 1% in Each Population and by Each Method
Population Number of Genes: Altrans asQTLs Altrans Number of Genes: Cufflinks asQTLs Cufflinks Overlap Overlap p Value
EUR 7,443 1,427 7,148 1,737 780 1.3 3 104
YRI 7,720 166 7,391 304 76 1.2 3 104
The overlap column lists the common genes between the methods and the p value refers to this overlap arising by chance.and permutated these for 100 times within the links of this
gene. We then measured the correlation of these random
assignments with the simulated ones and find that Cuf-
flinks and MISO fall to the levels of random assignment
of link quantifications as the novel transcripts increase in
the simulations. We estimated the proportion of novel
transcripts by using split read mappings from a well-
studied LCL transcriptome RNA-sequencing experiment7
and a less well-studied pancreatic beta cell transcriptome
RNA-sequencing experiment.25 We observe that in the
LCLs on average 25.8% (SD ¼ 3.5%) and in the beta cells
34.7% (SD ¼ 9.3%) of the junctions are not found in the
GENCODE v.12 annotation. Therefore we conclude that
in RNA-sequencing experiments where the annotation
does not fully reflect the underlying isoform variety, Al-
trans is a sensitive method for quantifying exon junctions.
cis-Alternative Splicing QTL Discovery and
Replication between Populations
The Geuvadis dataset comprises 373 European (EUR) and
89 African (YRI) samples and the cis-asQTL discovery was
conducted separately in each population as described in
the Material and Methods section. At an FDR threshold
of 1%, we find 1,472 and 1,737 asQTL genes in the Euro-
pean population with Altrans and Cufflinks, respectively.
For the Africans these numbers are 166 and 304, respec-
tively (Table 1). There is a significant overlap between the
methods in the asQTL genes, with Altrans finding approx-
imately 45% of the genes identified by Cufflinks in the
Europeans and about 25% in the Africans (Table 1).
The relative decrease of overlap between the methods in
the African population is due to the decreased samples
size, hence power, in this cohort compared to the Euro-
peans. When we plot the significant asQTLs distances
from the TSS, we observe that for bothmethods the asQTLs
that are shared between the two populations and asQTLs
with stronger effects tend to be closer to the TSS than pop-
ulation-specific and weaker asQTLs (Figure 3A). As ex-
pected, given the sample sizes of each population, majority
of the asQTLs genes in Europeans at this FDR threshold are
unique to this populations (91% for Altrans and 86% for
Cufflinks) whereas most of the African asQTLs genes are
also found in the Europeans (81% for Altrans and 82%
for Cufflinks) (Figure 3B). Using a more sensitive p1
approach,21 we estimate that 72% of the Altrans asQTLs
in Europeans are replicated in Africans and 94% of the
African asQTLs are replicated in Europeans. In the case of
Cufflinks, these estimates are 78% and 93%, respectively
(Figure 3C).The AmericWe have taken the correlation coefficient as a proxy to
the effect size of an asQTL and compared the absolute
value distribution of the correlation coefficients of signifi-
cant asQTLs identified by each method in both popula-
tions (Figure S1). Cufflinks asQTLs have significantly
higher effect sizes than Altrans asQTLs (Mann-Whitney
p< 1.693 105, indicating that Altrans is identifying asso-
ciations with smaller effect sizes compared to Cufflinks
and, together with changes in sample size, this contributes
to slight decrease of replication of European Altrans
asQTLs in Africans, compared to Cufflinks. Of note,
when we discover asQTLs in Africans (smaller sample
size) and replicate in Europeans (larger sample size), both
methods achieve very high levels of replication (94% and
93% for Altrans and Cufflinks, respectively). In order to
test the replication of asQTLs by each method indepen-
dent of sample size and different populations, we have
selected 91 European individuals belonging to the CEU
population and replicated the findings of this cohort in
the larger 282 remaining European samples. When we
calculate the p1 statistic in this analysis, we observe
that both methods attain very similar levels of replication
(p1 ¼ 95% for both methods) (Figure S2).
Differences between Methods
Given that both methods replicate at similar levels and
Cufflinks finds more asQTLs, one can make the argument
that this could be the method of choice. However, almost
half of the asQTLs that are discovered with Altrans are
unique to Altrans. Although the methodology in identi-
fying splicing QTLs in the original Geuvadis analysis dif-
fers significantly from the process described here, we also
checked the asQTL gene level overlap between the pub-
lished lists of splicing QTLs7 and the ones identified here
(Figure S3). We find that Altrans detects 258 out of the
620 asQTLs identified in the Europeans in the original
study, and Cufflinks finds 348 overlapping asQTLs. The
union of both methods used here identifies 395 genes as
significant asQTLs out of the 620 in the original discovery.
In the African population, the overlap proportions are
similar, with Altrans finding 16 out of 83 asQTLs as also sig-
nificant, whereas Cufflinks finds 35 common genes, and
the union of Altrans and Cufflinks overlaps with 38 asQTLs
in the original study. This is a confirmation of the comple-
mentary nature of asQTL discovery methods.
We investigated the Altrans-specific asQTLs further. First
we find that the majority of the Altrans-specific asQTLs
originate from links between exons that are not annotated
in the GENCODE v.12 annotation and therefore werean Journal of Human Genetics 97, 567–575, October 1, 2015 571
Figure 3. asQTL Discovery
(A) The relative distance of asQTLs to the TSS versus the p value.
(B) Mosaic plots of gene level sharing of asQTLs for each method at FDR ¼ 1%.
(C) The p value distributions of a variant-link pair tested in the other population for each method. From these p value distributions, the
p1 statistic is calculated that estimates the proportion of true positives.never tested by Cufflinks (89% and 83% not annotated for
Europeans and Africans, respectively; Figure S3). Next, we
assessed whether Altrans-specific discoveries replicate,
and to do so we tested the Altrans-specific discoveries orig-
inating from the 91 CEU individuals in the remaining
Europeans, and these associations achieve a p1 statistic of
93%, indicating a high true positive rate in Altrans-specific
asQTLs (Figure S4A). We also estimate that 63% of the
Altrans-specific asQTLs in Europeans are replicated in Afri-
cans and 95% of the African Altrans-specific asQTLs are
replicated in Europeans.
Moreover, we compared the types of splicing events that
are found to be significant by bothmethods (Figure S5) and
observed that there are differences between the two
methods. The majority (66%) of the signal that Altrans
captures is due to exon skipping events followed by alter-
native 50 and 30 UTRs (15% and 11%, respectively). In com-
parison, Cufflinks has a more uniform distribution of
significant event types, with the most common being
alternative 50 UTR (23%), followed by exon skipping
(15%) and alternative first exons (14%). This difference
in types of significant splicing events each method finds
highlights their relative merits in identifying different
types of splicing events and is one of the reasons for
method-specific significant results. We have tested
whether the exon skipping events identified by Altrans
replicate between CEU discovery and remaining Euro-
peans, and across populations, and we achieve high p1
values of 98% for CEU discovery replicated in remaining
Europeans (Figure S4B), 70% for Europeans replicated in572 The American Journal of Human Genetics 97, 567–575, OctoberAfricans, and 96% in Africans replicated in Europeans,
which confirms that these events are enriched for true
positives.
Replication of Discoveries by One Method in the
Other Method
We wanted to assess how discoveries of one method
compared to the other. For each significant variant-link
pair in one population by one method, we calculated the
p value of the same variant-link pair in the same popula-
tion based on quantifications by the other method. For
this we had to select common links identified by each
method, and therefore many genes are not being tested
for replication acrossmethods. From these p value distribu-
tions, we calculated the p1 statistic, which indicates the
proportion of true positives (Figure S6). We estimate that
94% of Altrans asQTLs in Europeans and 90% Altrans
asQTLs in Africans are replicated by Cufflinks quantifica-
tions in the corresponding population, for the common
links between the two methods. In contrast, replication in
the other direction, Cufflinks asQTLs in Altrans, is lower:
57% and 51% for Europeans and Africans, respectively.
When we are testing Altrans results in Cufflinks, we are
testing 507 and 77 genes for Europeans and Africans,
respectively, and when testing Cufflinks in Altrans, these
values are 1,260 and 230, respectively. We then multiply
the corresponding p1 values with these number of genes
tested to get an estimate of the number of genes that repli-
cate across methods and divide these with the correspond-
ing number of asQTL genes found in the original discovery1, 2015
Figure 4. Functional Enrichments of asQTLs Discovered by Altrans and Cufflinks
All variants identified in separate populations are merged. The null (frequency and distance matched) is represented as the black hori-
zontal line. The numbers above each bar are the log10 p values of the enrichment, Altrans enrichment p value followed by Cufflinks
p value.(e.g., for European Cufflinks in Altrans: 1,260 3 0.57 /
1,737 ¼ 41%). In doing so we estimate the percentage of
genes that are ‘‘discoverable’’ by theothermethod. This per-
centage is similar across methods and is in the Europeans
33% and 41% for Altrans and Cufflinks, respectively. In
the Africans these values are 42% and 39%. This is due to
the different space of alternative splicing that eachmethod
is best at quantifying and is another confirmation of the
complementary nature of these methods.
Functional Relevance of asQTLs
In the absence of a known and true set of asQTLs, we can
use the functional annotation of the human genome
generated by the ENCODE project to assess whether the
asQTLs discovered are likely to be biologically active. If
the identified asQTLs are ‘‘real,’’ then we would expect
them to lie in biochemically functional regions of the
genome more often than expected by chance. We have
tested this by overlapping asQTLs with functional annota-
tions provided by the Ensemble regulatory build24 and
comparing this overlap to that of random set non-asQTL
variants, which were matched to the asQTLs based on rela-
tive distance from TSS and allele frequency (Material and
Methods). We find significant enrichments for many tran-
scription factor peaks (median 5.23 median p ¼ 4.41 3
108 for Altrans and median 4.43 median p ¼ 2.26 3
107 for Cufflinks), DNase1 hypersensitive sites (4.23
p ¼ 1.53 3 1046 for Altrans and 2.93 p ¼ 5.05 3 1023
for Cufflinks), chromatin marks for active promoters (me-
dian 4.33median p¼ 1.513 1051 for Altrans andmedian
4.03 median p ¼ 5.15 3 1054 for Cufflinks), as well as
strong enhancer marks (median 3.93 median p ¼ 3.46 3
1040 for Altrans and median 3.43 median p ¼ 2.76 3
1035 for Cufflinks) in asQTLs identified by both methods
(Figure 4). We also observe a significant depletion in
repressor marks (3.33 p ¼ 3.51 3 1017 for Altrans andThe Americ5.03 p ¼ 2.28 3 1026 for Cufflinks). All together these re-
sults confirm the functional relevance of asQTLs and indi-
cate that we are capturing true biological signal. Further-
more, we also observe strong significant enrichments for
variants that are in splice acceptor (33.33 p ¼ 8.36 3
109 for Altrans and 553 p ¼ 2.25 3 1010 for Cufflinks)
and donor (103 p ¼ 0.01 for Altrans and 303 p ¼ 1.34 3
105 for Cufflinks) sites as well as variants in splice regions
(12.33 p ¼ 4.83 3 1028 for Altrans and 12.83 p ¼ 2.31 3
1037 for Cufflinks), which also indicates that we are
capturing variants involved in splicing machinery.Discussion
Here we present a method, Altrans, for relative quantifica-
tion of splicing events (Figure 1) to be used in population
genetics studies in discovery of asQTLs. Because the
phenotype is splicing ratios of exon links calculated from
mapping of RNA-sequencing reads without modeling of
transcript structure, it is a more direct estimation of
splicing. We have assessed the performance of the Altrans
algorithm versus the Cufflinks method both on simulated
and biological data. The simulation analysis indicates that
when the annotation perfectly describes the underlying
isoform variety, Cufflinks performs better than Altrans.
Because there is no easy way to generate junction annota-
tions that is used by MISO, and because we needed to have
a common annotation in all analysis (we could not use the
junctions provided in the MISO website), we chose to
quantify transcripts rather than junctions. Although
MISOmight perform better if we had quantified junctions,
the analysis performed is equivalent to the one with Cuf-
flinks, and still MISO underperforms compared to
Cufflinks. The reason Altrans is worse when compared to
Cufflinks in the presence of a perfect annotation is thatan Journal of Human Genetics 97, 567–575, October 1, 2015 573
Cufflinks quantifies transcript rather than exon links, i.e.,
it uses the total length of the transcript in quantifications,
whereas Altrans uses only the observed reads that are link-
ing a pair of exons. When we convert the transcript quan-
tifications of Cufflinks into link quantifications, this
means that all the links in a transcript will ‘‘borrow’’ infor-
mation from other links of the transcript, whereas in
Altrans all the links will be independently measured from
the observed reads overlapping the link. Moreover, when
the perfect annotation is available using transcript quanti-
fications, as in the case of Cufflinks, then Cufflinks is a
more accurate approach. However, the simulations also
show that when there are novel transcripts, i.e., isoforms
that are not represented in the annotation, the accuracy
of transcript quantifications decreases for Cufflinks and
MISO whereas Altrans quantifications do not suffer as
much as the transcript quantifications. We estimate that
in less well-studied transcriptomes like the human pancre-
atic beta cell transcriptome,25 the proportion of the links
between exons that are novel would be high enough that
using the known annotation can result in unreliable
estimates.
It is important to assess the performance of a method us-
ing biological data, and we applied Altrans and Cufflinks to
the Geuvadis dataset7 with the specific aim of identifying
asQTLs. We find 1,427 and 1,737 asQTL genes in the Euro-
pean population and 166 and 304 asQTLs in the Africans
with Altrans and Cufflinks, respectively. Using two subsets
from the European samples, we show that Altrans and Cuf-
flinks achieve similar levels of replication. Altrans-specific
asQTLs accounts for 45% of this method’s discovery,
which we show is mainly due to it quantifying junctions
that are not annotated in the reference. Moreover, these
Altrans-specific asQTLs replicate as well as the common
genes, indicating that they are probably true positives.
The other reason for the method-specific asQTLs is the
different types of alternative splicing events each method
captures (Figure S4). Altrans is more powerful in capturing
exon skipping events, whereas Cufflinks appears to be as
powerful in capturing events in the ends of transcripts.
This is an expected result given how each method works.
Because Altrans is examining reads that link multiple
exons, it will perform relatively poorly when a read pair
has to extend over constitutive parts of exon groups if
constitutive parts are larger than the insert size of the
experiment, because there will be very few reads joining
these types of exons. On the other hand, because Cufflinks
uses all reads over a transcript, it will not fail to quantify
these types of events accurately and this is reflected in
the types of events each algorithm identifies. Furthermore,
when we compare replication of results of one method by
the other method and account for the overlap of observed
links between the two methods, we find similar levels
of overlap between the detectable discoveries for each
method.
The relevance of the asQTLs identified by both methods
is confirmed by their significant overlap with functional574 The American Journal of Human Genetics 97, 567–575, Octoberannotations. This result, in the absence of a compre-
hensive list of asQTLs, shows that asQTLs that we are
capturing reside in biochemically active regions of the
genome, which reaffirms that we are capturing real biolog-
ical signal.
RNA sequencing allows us to comprehensively measure
transcript diversity in different cells types at the popula-
tion scale. However, quantifying alternative splicing from
short read length RNA sequencing remains a challenge.
This problem will be alleviated when technologies that
would permit sequencing of full-length transcripts, like
nanopore sequencing,26 become available, reliable, and
are cost effective in population studies. Currently all
methods have to infer quantifications of transcripts or
splice junctions, and each method in doing so has its rela-
tive merits. Here we present a different approach to this
problem, called Altrans, and show that it is sensitive and
performs comparably to other methods. We show that it
is capable of identifying thousands of asQTLs, many of
which are missed by other methods. We believe it will
prove useful in the search for alternative splicing QTLs in
population genetics studies.Supplemental Data
Supplemental Data include six figures and can be found with this
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